Eumentis Therapeutics Inc.
PrivateLast Round
Debt
Jun 26, 2024
Total Funding Raised
$36.17M
Company Overview
Eumentis Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops novel therapeutics for the treatment of neuropsychiatric and neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eumentis Therapeutics Inc. Comparables
Compare Eumentis Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noema Pharma | 82% | |
| Merck & Co., Inc. | 79% | |
| Celon Pharma | 78% | |
Eumentis Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 26, 2024 | ||||
| Series B | Feb 15, 2023 | ||||
| Grant | Feb 8, 2023 | ||||
| Debt | Apr 15, 2022 | ||||
| Series A | Oct 27, 2020 | ||||
Seed | Sep 2, 2020 |
Eumentis Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Joyance Partners | Seed |
| Social Starts | Seed |
| TCA Venture Group | Series A, Seed |
| Life Science Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2024
$765K raised in debt financing.
- Feb 8, 2023
$3M grant from the United States Department of Defense.
Eumentis Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eumentis Therapeutics Inc.'s valuation, stock price, and market status.